November Pharma and CRO Spatial Summit
Summit, Virtual Seminar
NOVEMBER 16, 9 AM PT / 12 PM ET
*A Virtual Event
Advancing Standard Tissue Analysis Practices
Don’t miss out on the opportunity to hear the first rollout of the NanoString GeoMx® DSP Best Practices Guidance as a cross-industry Pharma and CRO collaboration initiative.
The last NanoString Pharma and CRO Spatial summit focused on scaling GeoMx® workflows for large studies in biopharma. We will continue the next Summit on this topic and will hear from Contract Research Organizations (CROs), and their analytical verification approaches to support drug discovery and development studies.
If you are a current GeoMx® DSP user or are interested in learning about the execution of spatial biology studies, join us to learn more about:
- Best practices for implementation of biopharma studies using GeoMx
- Considerations for morphology marker and ROI selection strategies
- Biopharma applications
- Analytical verification studies
Program Agenda
| Time (PT) | Session | Speaker |
|---|---|---|
| 9:00 am | Welcome and Introduction to GeoMx | Jay Clark Senior Technical Sales Specialist NanoString |
| 09:20 am | GeoMx Best Practices Initiative | Espy Anguiano, PhD Scientific Market Development Director-BioPharma NanoString |
| 09:40 am | Analytical validation of the GeoMx Cancer Transcriptome Atlas for comprehensive spatial profiling of solid tumor samples | Lakshmi Chandramohan, Ph.D.D(ABMM) Principal Scientist and Associate Director, Molecular Assay Services, Pharma NeoGenomics Laboratories |
| 10:00 am | Digital Spatial Profiling: Transcriptional Analysis in Tumor Tissues | Shanshan Zhou, PhD Manager and Lead Scientist, Molecular Pathology and Companion Diagnostics Labcorp Drug Development |
| 10:20 am | Bridging the gap between pathology image analysis and spatial transcriptomics | Regan Baird, PhD Vice President Strategic Sales, Americas |
| 10:40 am | Optimizing Success in GeoMx Spatial Transcriptomics Studies | Lester Kobzik, MD Chief Medical Officer Cellecta, Inc. |
| 11:00 am | Panel Discussion + Live Q&A | Moderated by Espy Anguiano |
| 11:20 am | Closing Remarks |
